NewGenIvf Group

NewGenIvf Group Gross Margin

The Gross Margin of NewGenIvf Group (NIVF) as of Oct 20, 2026 is 20.22 %. In the previous year, Gross Margin was 33.63 % — a change of -39.86% (lower).

Gross Margin

20.22 %

YoY

-39.86%

Last updated:

Gross Margin of NewGenIvf Group is 2025 20.22 % . Gross Margin of NewGenIvf Group was 2024 33.63 % . It decreases by -39.86% lower compared to the previous year.

For NewGenIvf Group, the gross margin of 23.3% is down versus 25.4% a few years ago.

The NewGenIvf Group Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2021
24.89 USD
Jan 1, 2022
25.87 USD
Jan 1, 2023
32.74 USD
Jan 1, 2024
33.63 USD
Jan 1, 2025
20.22 USD
The NewGenIvf Group Gross Margin history
YEARGross MarginYoY
20.22 %-39.86%
33.63 %+2.70%
32.74 %+26.57%
25.87 %+3.93%
24.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewGenIvf Group Stock analysis

What does NewGenIvf Group do? NewGenIvf Group Ltd provides comprehensive fertility services across Asia, including IVF, ICSI, IUI, and MRT techniques. The company operates clinics in Thailand, Cambodia, and Kyrgyzstan, offering treatments such as embryo transfer, chromosome screening, egg freezing, and sperm aspiration. Patients seeking assisted reproductive technology services, including those requiring third-party egg donation or surrogacy, are the primary customers. The firm generates revenue through direct patient fees for these specialized fertility treatments and related services across its Asian clinics. The company's service portfolio includes Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), semen analysis, and sperm extraction procedures. These services are delivered through clinics in Thailand, Cambodia, and Kyrgyzstan, targeting individuals and couples facing infertility challenges. Revenue is derived from the full range of fertility treatments provided at these locations. NewGenIvf Group Ltd's offerings encompass full-spectrum infertility care, including egg and sperm donation programs and surrogacy services within compliant jurisdictions. The clinics serve patients requiring advanced reproductive technologies, with MRT being a specialized service involving third-party egg contribution. The business model relies on direct patient payments for all treatment packages and ancillary services provided at its Asian locations. NewGenIvf Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewGenIvf Group stock

Gross Margin of NewGenIvf Group is 20.22 % in 2025.

Gross Margin of NewGenIvf Group changed from 33.63 % to 20.22 %, representing a -39.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin NewGenIvf Group since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's NewGenIvf Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — NewGenIvf Group

All Key Metrics — NewGenIvf Group